The Technical Analyst
Select Language :
Millendo Therapeutics Inc [MLND]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Millendo Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Millendo Therapeutics Inc is listed at the  Exchange

-5.36% $1.060

America/New_York / 28 jun 2021 @ 00:00


Millendo Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 11.15 mill
EPS: 0
P/E: 0
Earnings Date: N/A
SharesOutstanding: 10.52 mill
Avg Daily Volume: 0.141 mill
RATING 2022-02-09
B+
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Neutral
DE: Buy
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
1/192/191/202/201/212/21
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebitn/an/an/a
Asset n/an/an/a
Debtn/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.966 - 1.154

( +/- 8.87%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2020-06-22 Nuechterlein Carole Buy 12 000 Stock Option (right to buy)
2020-06-22 Howe John P Md Buy 12 000 Stock Option (right to buy)
2020-06-22 Gallagher Carol Giltner Buy 12 000 Stock Option (right to buy)
2020-06-22 Nichol Geoffrey Buy 12 000 Stock Option (right to buy)
2020-06-22 Hindman James M. Buy 12 000 Stock Option (right to buy)
INSIDER POWER
0.00
Last 34 transactions
Buy: 816 539 | Sell: 0

Forecast: 01:40 - $0.843

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.060 (-5.36% )
Volume 1.913 mill
Avg. Vol. 0.141 mill
% of Avg. Vol 1 356.71 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Millendo Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Millendo Therapeutics Inc

RSI

Intraday RSI14 chart for Millendo Therapeutics Inc

Last 10 Buy & Sell Signals For MLND

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Millendo Therapeutics Inc

MLND

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

Last 10 Buy Signals

Date Signal @
XAUTUSDMar 29 - 07:19$2 232.78
POLYXUSDMar 29 - 07:190.529
VRXUSDMar 29 - 07:1862.71
TOMOUSDMar 29 - 07:13$1.061
POOLXUSDMar 29 - 07:095.22
COREUSDMar 29 - 07:086 994.98
PENDLEUSDMar 29 - 07:094.21
BFICUSDMar 29 - 07:079.89
RETH2USDMar 29 - 06:593 540.59
PUNDIXUSDMar 29 - 06:580.696

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.